1072 related articles for article (PubMed ID: 24345633)
21. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
Homburg R; Ray A; Bhide P; Gudi A; Shah A; Timms P; Grayson K
Hum Reprod; 2013 Apr; 28(4):1077-83. PubMed ID: 23377771
[TBL] [Abstract][Full Text] [Related]
22. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
[TBL] [Abstract][Full Text] [Related]
24. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
[TBL] [Abstract][Full Text] [Related]
25. The physiology and clinical utility of anti-Mullerian hormone in women.
Dewailly D; Andersen CY; Balen A; Broekmans F; Dilaver N; Fanchin R; Griesinger G; Kelsey TW; La Marca A; Lambalk C; Mason H; Nelson SM; Visser JA; Wallace WH; Anderson RA
Hum Reprod Update; 2014; 20(3):370-85. PubMed ID: 24430863
[TBL] [Abstract][Full Text] [Related]
26. Can we use serum Anti-Mullerian hormone to differentiate the diagnosis between polycystic ovary syndrome patients and healthy women with polycystic ovarian morphology and regular menstrual cycles.
Aydoğmuş H; Kelekçi S; Elmalı F; Aydoğmuş S
Saudi Med J; 2018 Oct; 39(10):1011-1016. PubMed ID: 30284584
[TBL] [Abstract][Full Text] [Related]
27. Relationship between serum anti-Mullerian hormone and clinical parameters in polycystic ovary syndrome.
Matsuzaki T; Munkhzaya M; Iwasa T; Tungalagsuvd A; Yano K; Mayila Y; Yanagihara R; Tokui T; Kato T; Kuwahara A; Matsui S; Irahara M
Endocr J; 2017 May; 64(5):531-541. PubMed ID: 28381699
[TBL] [Abstract][Full Text] [Related]
28. AMH MEASUREMENT VERSUS OVARIAN ULTRASOUND IN THE DIAGNOSIS OF POLYCYSTIC OVARY SYNDROME IN DIFFERENT PHENOTYPES.
Carmina E; Campagna AM; Fruzzetti F; Lobo RA
Endocr Pract; 2016 Mar; 22(3):287-93. PubMed ID: 26523627
[TBL] [Abstract][Full Text] [Related]
29. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
30. Discordance between serum anti-Müllerian hormone concentrations and antral follicle counts: not only technical issues.
Alebic MŠ; Stojanovic N; Dewailly D
Hum Reprod; 2018 Jun; 33(6):1141-1148. PubMed ID: 29688494
[TBL] [Abstract][Full Text] [Related]
31. Follicle number, not assessments of the ovarian stroma, represents the best ultrasonographic marker of polycystic ovary syndrome.
Christ JP; Willis AD; Brooks ED; Vanden Brink H; Jarrett BY; Pierson RA; Chizen DR; Lujan ME
Fertil Steril; 2014 Jan; 101(1):280-287.e1. PubMed ID: 24188871
[TBL] [Abstract][Full Text] [Related]
32. The relationship between anti-Mullerian hormone, androgen and insulin resistance on the number of antral follicles in women with polycystic ovary syndrome.
Chen MJ; Yang WS; Chen CL; Wu MY; Yang YS; Ho HN
Hum Reprod; 2008 Apr; 23(4):952-7. PubMed ID: 18256110
[TBL] [Abstract][Full Text] [Related]
33. Reconciling the definitions of polycystic ovary syndrome: the ovarian follicle number and serum anti-Müllerian hormone concentrations aggregate with the markers of hyperandrogenism.
Dewailly D; Pigny P; Soudan B; Catteau-Jonard S; Decanter C; Poncelet E; Duhamel A
J Clin Endocrinol Metab; 2010 Sep; 95(9):4399-405. PubMed ID: 20610596
[TBL] [Abstract][Full Text] [Related]
34. Ovarian morphology in polycystic ovary syndrome: estimates from 2D and 3D ultrasound and magnetic resonance imaging and their correlation to anti-Müllerian hormone.
Nylander M; Frøssing S; Bjerre AH; Chabanova E; Clausen HV; Faber J; Skouby SO
Acta Radiol; 2017 Aug; 58(8):997-1004. PubMed ID: 28273731
[TBL] [Abstract][Full Text] [Related]
35. Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS).
Hoyos LR; Visser JA; McLuskey A; Chazenbalk GD; Grogan TR; Dumesic DA
Hum Reprod; 2020 Oct; 35(10):2294-2302. PubMed ID: 32918081
[TBL] [Abstract][Full Text] [Related]
36. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
Łebkowska A; Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Milewski R; Górska M; Wołczyński S; Kowalska I
Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579
[TBL] [Abstract][Full Text] [Related]
37. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
38. The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology.
Vural F; Vural B; Kardaş E; Ertürk Coşkun AD; Yildirim İ
Arch Gynecol Obstet; 2023 Apr; 307(4):1083-1090. PubMed ID: 36565362
[TBL] [Abstract][Full Text] [Related]
39. Intraindividual right-left comparison of sonographic features in polycystic ovary syndrome (PCOS) diagnosis.
Köninger A; Koch L; Edimiris P; Nießen S; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():124-9. PubMed ID: 25150949
[TBL] [Abstract][Full Text] [Related]
40. Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome.
Pigny P; Jonard S; Robert Y; Dewailly D
J Clin Endocrinol Metab; 2006 Mar; 91(3):941-5. PubMed ID: 16368745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
